IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Valeant Pharmaceuticals

CUSIP: 91911X104 | 16 institutional holders

Quarters

Q3 2019Q2 2018Q1 2018Q4 2017Q3 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2019

Syntal Capital Partners, LLC9,500
0.0% of portfolio›$380
StyleTurnoverLocationFiled
Syntal Capital Partners, LLC
9,500$3800.0%N/AN/AMidland, TX2019-11-14